Back to Search Start Over

Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eye.

Authors :
Mettler C
Petit C
Ernest V
Asli B
Daniel MT
Mathis S
Zini JM
Faucher B
Ebbo M
Legendre P
Malphettes M
Source :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2022 Mar; Vol. 236, pp. 108951. Date of Electronic Publication: 2022 Feb 05.
Publication Year :
2022

Abstract

Erythroblastic synartesis is a rare cause of acquired dyserythropoiesis. Only 9 cases have been previously reported. We hereby report 3 cases of patients diagnosed with erythroblastic synartesis associated with monoclonal immunoglobulin and an overt malignant lymphoid disorder. A different B-cell clone may produce the monoclonal immunoglobulin, forming a biclonal disorder. In light of these data and literature review, treatment targeting the paraprotein seems to be efficient to control synartesis and correct anemia. In the case of monoclonal gammapathy associated with chronic lymphocytic leukemia, therapeutics should be adapted to control both chronic lymphocytic leukemia and monitored monoclonal immunoglobulin titer.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1521-7035
Volume :
236
Database :
MEDLINE
Journal :
Clinical immunology (Orlando, Fla.)
Publication Type :
Academic Journal
Accession number :
35134549
Full Text :
https://doi.org/10.1016/j.clim.2022.108951